Description
Market Report Coverage – Radiofrequency-Based Devices
Market Segmentation
• Product – Generators, Electrodes, Applicators, Probes, Cannulas, Needles, Others (Pumps, Pads, Clamps, Forceps, Wires, Sheaths, Footswitches)
• Application – Pain Management, Aesthetics, Oncology, Cardiology, Others (ENT, Gynecology, Urology, General Surgery)
• End User – Hospital, Ambulatory Surgical Centers, and Specialty Clinics, Others (Rehabilitation Centers, Nursing Homes, and Research and Academic Institutions)
Regional Segmentation
• North America – U.S., Canada
• Europe – Germany, France, Italy, U.K., Spain, Netherlands, Switzerland, Rest-of-Europe
• Asia-Pacific – Japan, China, India, South Korea, Australia and New Zealand, Singapore, Rest-of-Asia-Pacific
• Latin America – Brazil, Mexico, Rest-of-Latin America
• Rest-of-the-World
Growth Drivers
• Rising Incidence of Chronic Diseases
• Increase in Geriatric Population
• Advantages Over Traditional Ablation and Aesthetic Treatment Methods
• Increasing Awareness Toward Aesthetic Treatments
• Technological Advancement in the Radiofrequency-Based Devices
Market Challenges
• High Cost Associated with Radiofrequency-Based Treatments
• Lack of Skilled Healthcare Professionals
• Restrictive Reimbursement Landscape
Market Opportunities
• Development of Low-Cost Radiofrequency-Based Systems
• Better Healthcare Infrastructure and Increase in Awareness Toward Radiofrequency-Based Devices in Developing Nations
Key Radiofrequency-Based Companies Profiled
Abbott Laboratories, AngioDynamics, Inc., ALMA Lasers (Sisram Medical Ltd), ArtiCure, Inc., Avanos Medical, Inc., Boston Scientific Corporation, CONMED Corporation, Cutera, Inc., Medtronic plc, Merit Medical Systems, Inc., Smith & Nephew, Stryker Corporation, Venus Concept, Inc., Bramsys Indústria e Comércio Ltda, BVM Medical Limited, Diros Technology Inc.
Key Questions Answered in this Report:
• What are the key regulations abiding the development, commercialization, and clinical use of radiofrequency-based devices, across different regions?
• What are the key technological developments on which the current industry leaders are spending their major share of research and development (R&D) investment?
• Who are the leading players holding significant dominance on the global radiofrequency-based devices market, currently?
• What are the key strategies incorporated by the players of the global radiofrequency-based devices market, to sustain the competition and retain their supremacy?
• What is the current annual demand for radiofrequency-based devices across different regions and what is their growth potential in the forecast period?
• What is the current market potential of radiofrequency technology, and what are the factors deciding the growth potential of radiofrequency technology in the forecast period?
• What is the current revenue contribution of different product types in the radiofrequency-based devices market, and how would it evolve in the forecast period?
• What is the current revenue contribution of different applications in the radiofrequency-based devices market, and how would it evolve in the forecast period?
• Is the overall radiofrequency-based devices market expected to grow or contract in the future? Why?
• What are the similar technologies available in the market? How do the alternative technologies compare and impact global radiofrequency-based devices market?
• What are the major technological investments happening in the radiofrequency-based devices market by the key players?
• Which is the pricing analysis of the radiofrequency-based products and procedures?
• Which radiofrequency-based devices applications segment is growing and contracting, respectively? Why?
• What is the current and future market scenario of the global radiofrequency-based devices market?
• What are the different entities in the supply chain analyses for the radiofrequency-based devices market?
Market Overview
Reducing the impact of surgical interventions on patients has been the direction of evolution for surgery in the last few decades. Acknowledging the benefits, such as low blood loss, low post-operative recovery time, the lower possibility for post-operative infections and complications, and above all, lower chance of requirement of a revision procedure, minimally invasive surgical technologies have been witnessing impressive growth in demand across the globe.
The growing demand for MIS procedures has consequentially resulted in massive demand for image-guided ablation treatments. One of the predominant image-guided treatments employed in minimally invasive surgical procedures radiofrequency ablation (RFA). RFA has emerged as the most commonly used technology for thermal ablation in bone, kidney, liver, lung, heart, breast, lymph nodes, nerves, and soft tissues, among others.
Radiofrequency-based devices are also used in aesthetic treatments, such as skin tightening, wrinkle reduction, skin, and neck laxity, and body contouring, among others in a non-invasive manner.
Healthcare experts at BIS Research have found radiofrequency to be one of the most rapidly evolving technologies, and the global market for radiofrequency-based devices is predicted to grow at a CAGR of 12.81% over the forecast period of 2021-2030. The market is driven by certain factors, which include the rising incidence of chronic disorders, elevating geriatric population, rising demand for minimally invasive surgical procedures, the increasing amount of healthcare spending in developing economies, and technological advancements in the field of ablation and aesthetic treatments.
There is a significant opportunity for the growth of the global radiofrequency-based devices market during the next ten years. The rise in the geriatric population across the globe, as well as the rise in prevalence of chronic diseases, are driving the growth of RF-based devices for pain management, oncology, and cardiology applications. The adoption of advanced technologies, such as the use of multipolar radiofrequency devices, is also expected to drive patient acceptance for sophisticated ablative and non-ablative procedures.
Additional modalities, such as fractional RF, sublative RF, phase-controlled RF, and combination RF therapies that apply light, massage, or pulsed electromagnetic fields (PEMFs), are contributing to the rapid adoption of radiofrequency in aesthetic treatments.
Within the research report, the market is segmented on the basis of product type, application, end users, and region. Each of these segments covers the snapshot of the market over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.
Competitive Landscape
The key players have predominantly been involved in M&A activities, launched new products, and ventured into synergistic partnerships aimed at either co-developing new technologies or strengthening consumer reach by combining marketing efforts of both the companies.
Companies such as Stryker Corporation, Boston Scientific Corporation, Johnson & Johnson, Becton Dickinson and Company, Smith & Medical, Avanos Medical, YA MAN LTD., Cynosure, Medtronic plc, Venus Concept Inc, and Abbott Laboratories are expected to maintain their market dominance during the forecast period.
On the basis of region, North America holds the largest share of installed base and units sold due to improved healthcare infrastructure, rise in per capita income, and improvised reimbursement policies in the region. Apart from this, Asia-Pacific and Latin America regions are anticipated to grow at the fastest CAGR during the forecast period.
Table of Contents
Executive Summary
1 Product Definition
2 Scope of Research Study
2.1 Research Scope
2.2 Inclusion and Exclusion Criteria
2.3 Key Questions Answered in the Report
3 Research Methodology
3.1 Primary Research
3.2 Secondary Research
3.3 Data Sources Categorization
3.4 Companies Profiled in the Report
3.5 Market Estimation and Market Forecast Methodology
3.6 Data Validation
3.7 Assumptions and Limitations
4 Industry Analysis
4.1 Supply Chain Analysis
4.2 Regulatory Framework and Government Initiatives
4.2.1 Regulations in the U.S.
4.2.2 Regulations in Canada
4.2.3 Regulations in Europe
4.2.4 Regulations in Asia-Pacific
4.2.4.1 National Medical Products Administration (NMPA)
4.2.4.2 Pharmaceutical and Medical Device Agency (PMDA)
4.3 Associations and Consortiums
4.4 Patent Analysis
4.4.1 Patent Search Strategy
4.4.2 Cooperative Patent Classification (CPC) for Radiofrequency-Based Devices
4.4.3 Top Assignees
4.4.4 Granted Patents Trend
5 Competitive Landscape
5.1 Market Share Analysis (by Company)
5.2 Market Share Analysis (by Product)
5.3 Key Strategies and Developments
5.3.1 M&A Activities
5.3.2 Regulatory and Legal
5.3.3 New Offerings
5.3.4 Partnerships, Alliances, and Business Expansions
5.3.5 Funding Activities
5.4 Growth Share Matrix
5.5 Application Analysis
5.6 Pricing Analysis
6 Global Radiofrequency-Based Devices Market Sizing and Forecast
6.1 Assumptions and Limitations
6.2 Key Findings and Opportunity Analysis
6.3 Impact of COVID-19 on Radiofrequency-Based Devices Market
6.4 Global Radiofrequency-Based Devices Market Size and Forecast
6.5 Market Dynamics
6.5.1 Market Drivers
6.5.1.1 Upsurge in the Number of Chronic Diseases
6.5.1.2 Increasing Demand for Minimally Invasive Procedure
6.5.1.3 Increase in Geriatric Population
6.5.1.4 Advantages Over Other Ablation and Aesthetic Treatments
6.5.1.5 Technological Advancements in Radiofrequency-Based Devices
6.5.1.6 Increasing Awareness Toward Aesthetic Treatments
6.5.2 Market Restraints
6.5.2.1 High Costs Associated with Radiofrequency-Based Treatments
6.5.2.2 Lack of Reimbursement Policies for Pain Management and Aesthetic Treatments
6.5.2.3 Lack of Skilled Healthcare Professionals
6.5.3 Impact Analysis
7 Global Radiofrequency-Based Devices Market (by Product)
7.1 Overview
7.2 Radiofrequency Generators/Systems
7.3 Electrodes (Single-Use, Reusable)
7.4 Applicators (Handpieces)
7.5 Probes (Single-Use, Reusable)
7.6 Cannulas
7.7 Needles
7.8 Others (Catheters, Footswitches, Pumps, Pads, RF Wires, Sheaths, Clamps, and Forceps)
8 Global Radiofrequency-Based Devices Market (by Application)
8.1 Overview
8.2 Pain Management
8.3 Aesthetics
8.4 Oncology
8.5 Cardiology
8.6 Others (ENT, Gynecology, Urology, and General Surgery)
9 Global Radiofrequency-Based Devices Market (by End User)
9.1 Overview
9.2 Hospitals
9.3 Ambulatory Surgical Centers (ASCs) and Specialty Clinics
9.4 Others (Rehabilitation Centers, Nursing Homes, Research, and Academic Institutions)
10 Global Radiofrequency-Based Devices Market (by Region)
10.1 Overview
10.2 North America Radiofrequency-Based Devices Market
10.2.1 Key Findings
10.2.2 Market Size and Forecast
10.2.3 North America Radiofrequency-Based Devices Market (by Country)
10.2.3.1 U.S.
10.2.3.2 Canada
10.3 Europe Radiofrequency-Based Devices Market
10.3.1 Key Findings
10.3.2 Market Size and Forecast
10.3.3 Market Dynamics
10.3.4 Europe Radiofrequency-Based Devices Market (by Country)
10.3.4.1 Germany
10.3.4.2 France
10.3.4.3 Italy
10.3.4.4 U.K.
10.3.4.5 Spain
10.3.4.6 Netherlands
10.3.4.7 Switzerland
10.3.4.8 Rest-of-Europe
10.4 Asia-Pacific Radiofrequency-Based Devices Market
10.4.1 Key Findings
10.4.2 Market Size and Forecast
10.4.3 Market Dynamics
10.4.4 Asia-Pacific Radiofrequency-Based Devices Market (by Country)
10.4.4.1 Japan
10.4.4.2 China
10.4.4.3 India
10.4.4.4 South Korea
10.4.4.5 Australia and New Zealand
10.4.4.6 Singapore
10.4.4.7 Rest-of-Asia-Pacific
10.5 Latin America Radiofrequency-Based Devices Market
10.5.1 Key Findings
10.5.2 Market Size and Forecast
10.5.3 Market Dynamics
10.5.4 Latin America Radiofrequency-Based Devices Market (by Country)
10.5.4.1 Brazil
10.5.4.2 Mexico
10.5.4.3 Rest-of-Latin America
10.6 Rest-of-the-World Radiofrequency-Based Devices Market
10.6.1 Key Findings
10.6.2 Market Size and Forecast
10.6.3 Market Dynamics
11 Company Profiles
11.1 Abbott Laboratories
11.1.1 Company Overview
11.1.2 Key Financials
11.1.3 Business Information
11.1.4 Abbott Laboratories: SWOT Analysis
11.2 AngioDynamics, Inc.
11.2.1 Company Overview
11.2.2 Key Financials
11.2.3 Business Information
11.2.4 AngioDynamics, Inc.: SWOT Analysis
11.3 ALMA Lasers (Sisram Medical Ltd)
11.3.1 Company Overview
11.3.2 Key Financials
11.3.3 Business Information
11.3.4 ALMA Lasers (Sisrem Medical Ltd): SWOT Analysis
11.4 AtriCure, Inc.
11.4.1 Company Overview
11.4.2 Key Financials
11.4.3 Business Information
11.4.4 ArtiCure, Inc.: SWOT Analysis
11.5 Avanos Medical, Inc.
11.5.1 Company Overview
11.5.2 Key Financials
11.5.3 Business Information
11.5.4 Avanos Medical, Inc.: SWOT Analysis
11.6 Boston Scientific Corporation
11.6.1 Company Overview
11.6.2 Key Financials
11.6.3 Business Information
11.6.4 Boston Scientific Corporation: SWOT Analysis
11.7 CONMED CORPORATION
11.7.1 Company Overview
11.7.2 Key Financials
11.7.3 Business Information
11.7.4 CONMED CORPORATION: SWOT Analysis
11.8 Cutera, Inc.
11.8.1 Company Overview
11.8.2 Key Financials
11.8.3 Business Information
11.8.4 Cutera, Inc.: SWOT Analysis
11.9 Medtronic, Plc
11.9.1 Company Overview
11.9.2 Key Financials
11.9.3 Business Information
11.9.4 Medtronic plc: SWOT Analysis
11.1 Merit Medical Systems, Inc.
11.10.1 Company Overview
11.10.2 Key Financials
11.10.3 Business Information
11.10.4 Merit Medical Systems, Inc.: SWOT Analysis
11.11 Smith & Nephew
11.11.1 Company Overview
11.11.2 Key Financials
11.11.3 Business Information
11.11.4 Smith & Nephew: SWOT Analysis
11.12 Stryker Corporation
11.12.1 Company Overview
11.12.2 Key Financials
11.12.3 Business Information
11.12.4 Stryker Corporation: SWOT Analysis
11.13 Venus Concept, Inc.
11.13.1 Company Overview
11.13.2 Key Financials
11.13.3 Business Information
11.13.4 Venus Concept, Inc.: SWOT Analysis
11.14 Bramsys Indústria e Comércio Ltda
11.14.1 Company Overview
11.14.2 Company Description
11.14.3 Bramsys Indústria e Comércio Ltda: SWOT Analysis
11.15 BVM Medical Limited
11.15.1 Company Overview
11.15.2 Company Description
11.15.3 BVM Medical Limited: SWOT Analysis
11.16 Diros Technology Inc.
11.16.1 Company Overview
11.16.2 Company Description
11.16.3 Diros Technology, Inc. Medical Limited: SWOT Analysis
List of Tables
Table 4.1: European Commission Medical Device Directives
Table 4.2: Classification of Radiofrequency-Based Devices According to the European Union
Table 4.3: Regulatory Bodies in Asia-Pacific
Table 4.4: List of Associations/Consortiums with Year of Establishment and Headquarters
Table 4.5: Top Classes Referred in the Search Query for Radiofrequency-Based Devices Market
Table 4.6: Top Assignees of Radiofrequency Devices Based on Products, Procedures, and Technologies
Table 5.1: Top Players of Radiofrequency-Based Devices Market based on the Number of M&A Activities, January 2017-June 2020
Table 5.2: Top Players of Radiofrequency-Based Devices Market based on the Number of Regulatory and Legal Approvals, January 2017-June 2020
Table 5.3: Top Players of Radiofrequency-Based Devices Market based on the Number of New Offerings, January 2017-June 2020
Table 5.4: Top Players of Radiofrequency-Based Devices Market based on the Number of Partnerships, Alliances, and Business Expansions, January 2017-June 2020
Table 5.5: Top Players of Radiofrequency-Based Devices Market Based on the Number of Funding Activities, January 2017-June 2020
Table 5.6: Radiofrequency-Based Devices Applications Covered by Major Companies
Table 5.7: Cost Comparison for Equipment Used for Atrial Fibrillation Ablation
Table 8.1: Comparison of Current Tumor Ablation Therapies
Table 10.1: Macro-Economic Factors Driving the Growth of Radiofrequency-Based Devices Market in North America, 2016-2022
Table 10.2: Macro-Economic Factors Driving the Growth of Radiofrequency-Based Devices Market in the U.S., 2016-2022
Table 10.3: Macro-Economic Factors Driving the Growth of Radiofrequency-Based Devices Market in Canada, 2016-2022
Table 10.4: Macro-Economic Factors Driving the Growth of Radiofrequency-Based Devices Market in Europe, 2016-2022
Table 10.5: Macro-Economic Factors Driving the Growth of Radiofrequency-Based Devices Market in Germany, 2016-2022
Table 10.6: Macro-Economic Factors Driving the Growth of Radiofrequency-Based Devices Market in France, 2016-2022
Table 10.7: Macro-Economic Factors Driving the Growth of Radiofrequency-Based Devices Market in Italy, 2016-2022
Table 10.8: Macro-Economic Factors Driving the Growth of Radiofrequency-Based Devices Market in U.K., 2016-2022
Table 10.9: Macro-Economic Factors Driving the Growth of Radiofrequency-Based Devices Market in Spain, 2016-2022
Table 10.10: Macro-Economic Factors Driving the Growth of Radiofrequency-Based Devices Market in Netherlands, 2016-2022
Table 10.11: Macro-Economic Factors Driving the Growth of Radiofrequency-Based Devices Market in Switzerland, 2016-2022
Table 10.12: Macro-Economic Factors Driving the Growth of Radiofrequency-Based Devices Market in Asia-Pacific, 2016-2022
Table 10.13: Macro-Economic Factors Driving the Growth of Radiofrequency-Based Devices Market in Japan, 2016-2022
Table 10.14: Macro-Economic Factors Driving the Growth of Radiofrequency-Based Devices Market in China, 2016-2022
Table 10.15: Macro-Economic Factors Driving the Growth of Radiofrequency-Based Devices Market in India, 2016-2022
Table 10.16: Macro-Economic Factors Driving the Growth of Radiofrequency-Based Devices Market in South Korea, 2016-2022
Table 10.17: Macro-Economic Factors Driving the Growth of Radiofrequency-Based Devices Market in Australia and New Zealand, 2016-2022
Table 10.18: Macro-Economic Factors Driving the Growth of Radiofrequency-Based Devices Market in Latin America, 2016-2022
Table 10.19: Macro-Economic Factors Driving the Growth of Radiofrequency-Based Devices Market in Brazil, 2016-2022
Table 10.20: Macro-Economic Factors Driving the Growth of Radiofrequency-Based Devices Market in Mexico, 2016-2022
List of Figures
Figure 1: Global Radiofrequency-Based Devices Market Incremental Revenue Opportunity, $Million, 2020-2030
Figure 2: Impact Analysis for Key Market Drivers and Restraints in the Global Radiofrequency-Based Devices Market
Figure 3: Leading Players in Global Radiofrequency-Based Devices Market, 2019
Figure 4: Key Strategies Incorporated by Players of Global Radiofrequency-Based Devices Market, January 2017-June 2020
Figure 5: Global Radiofrequency-Based Devices Market (by Radiofrequency Generators/Systems), $Million, 2021-2030
Figure 6: Global Radiofrequency-Based Devices Market (by Application), 2019 vs. 2030
Figure 7: Growth Share Analysis for Region-Specific Demand for Radiofrequency-Based Devices, 2019
Figure 2.1: Global Radiofrequency-Based Devices (Market Segmentation)
Figure 2.2: Radiofrequency-Based Devices Market (by Region)
Figure 3.1: Global Radiofrequency-Based Devices Market Research Methodology
Figure 3.2: Primary Research
Figure 3.3: Secondary Research
Figure 3.4: Secondary Research
Figure 4.1: Key Entities of Supply Chain of Radiofrequency-Based Devices Market:
Figure 4.2: Global Radiofrequency-Based Devices Market Supply Chain Analysis
Figure 4.3: Activities Governed by Various Regulatory Bodies to Ensure the Safe and Effective Use of Radiofrequency-Based Devices
Figure 4.4: Global Radiofrequency-Based Devices Market: Regulatory Landscape
Figure 4.5: Regulatory Process for Class II Medical Devices in the U.S.
Figure 4.6: EU Regulatory Pathway for Medical Device
Figure 4.7: Radiofrequency-Based Devices Market Patent Count (by Country), January 2017–August 2020
Figure 4.8: Radiofrequency-Based Devices Market Patent Percentage Share (by Region and Country), January 2017–August 2020
Figure 4.9: Number of Granted Patents in Radiofrequency-Based Devices Market (by Year), 2017-2020
Figure 5.1: Global Radiofrequency-Based Devices Market (by Company), 2019
Figure 5.2: Global Radiofrequency-Based Devices Market (by Product), 2019
Figure 5.3: Key Developments and Strategies in the Global Radiofrequency-Based Devices Market (by Category), January 2016-June 2020
Figure 5.4: Key Developments in Radiofrequency-Based Devices Market (by Year), January 2017-June 2020
Figure 5.5: Global Radiofrequency-Based Devices Market Growth Share Matrix (by Product Type), 2019
Figure 5.6: Pricing Analysis of Radiofrequency-Based Products
Figure 6.1: Global Radiofrequency-Based Devices Market Incremental Revenue Opportunity, 2020-2030
Figure 6.2: Global Radiofrequency-Based Devices Market, $Million, 2019-2030
Figure 6.3: Global Pain Prevalence, Million, 2010-2017
Figure 6.4: Global Cancer Prevalence, Million, 2010-2017
Figure 6.5: Global Uterine Fibroids Prevalence, Million, 2010-2017
Figure 6.6: Global Atrial Fibrillation and Flutter Prevalence, Million, 2010-2017
Figure 6.7: Rising Demand for Minimally Invasive Surgical Procedures
Figure 6.8: Increasing Prevalence of Diseases (by Age Group), 2008-2017
Figure 6.9: Impact Analysis of Drivers and Restraints on Radiofrequency-Based Devices Market
Figure 7.1: Global Radiofrequency-Based Devices Market (by Product)
Figure 7.2: Global Radiofrequency-Based Devices Market Share (by Product), $Million, 2020-2030
Figure 7.3: Global Radiofrequency-Based Devices Market (for Radiofrequency Generators/Systems), $Million, 2019-2030
Figure 7.4: Global Radiofrequency-Based Devices Market (for Electrodes), $Million, 2019-2030
Figure 7.5: Global Radiofrequency-Based Devices Market (for Applicators), $Million, 2019-2030
Figure 7.6: Global Radiofrequency-Based Devices Market (for Probes), $Million, 2019-2030
Figure 7.7: Global Radiofrequency-Based Devices Market (for Cannulas), $Million, 2019-2030
Figure 7.8: Global Radiofrequency-Based Devices Market (for Needles), $Million, 2019-2030
Figure 7.9: Global Radiofrequency-Based Devices Market (for Others), $Million, 2019-2030
Figure 8.1: Global Radiofrequency-Based Devices Market (by Application)
Figure 8.2: Global Radiofrequency-Based Devices Market Share (by Application), $Million, 2019-2030
Figure 8.3: Global Radiofrequency-Based Devices Market (for Pain Management), $Million, 2019-2030
Figure 8.4: Global Radiofrequency-Based Devices Market (for Aesthetics), $Million, 2019-2030
Figure 8.5: Global Radiofrequency-Based Devices Market (for Oncology), $Million, 2019-2030
Figure 8.6: Global Radiofrequency-Based Devices Market (for Cardiology), $Million, 2019-2030
Figure 8.7: Global Radiofrequency-Based Devices Market (for Others), $Million, 2019-2030
Figure 9.1: Global Radiofrequency-Based Devices Market (by End User)
Figure 9.2: Global Radiofrequency-Based Devices Market (for Hospitals), $Million, 2019-2030
Figure 9.3: Global Radiofrequency-Based Devices Market (for Ambulatory Surgical Centers and Specialty Clinics), $Million, 2019-2030
Figure 9.4: Global Radiofrequency-Based Devices Market (for Others), $Million, 2019-2030
Figure 10.1: Global Radiofrequency-Based Devices Market (by Region), 2019-2030
Figure 10.2: Global Radiofrequency-Based Devices Market (by Region), $Million, 2019-2030
Figure 10.3: Global Radiofrequency-Based Devices Market Growth Share Matrix (by Region), 2019
Figure 10.4: Global Radiofrequency-Based Devices Market Growth Share Matrix (by Key Countries), 2019
Figure 10.5: North America Radiofrequency-Based Devices Market, $Million, 2019-2030
Figure 10.6: North America Radiofrequency-Based Devices Market (by End User), $Million, 2019-2030
Figure 10.7: North America: Market Dynamics
Figure 10.8: U.S. Radiofrequency-Based Devices Market, $Million, 2019-2030
Figure 10.9: U.S. Radiofrequency-Based Devices Market (by End User), $Million, 2019-2030
Figure 10.10: Canada Radiofrequency-Based Devices Market, $Million, 2019-2030
Figure 10.11: Canada Radiofrequency-Based Devices Market (by End User), $Million, 2019-2030
Figure 10.12: Europe Radiofrequency-Based Devices Market, $Million, 2019-2030
Figure 10.13: Europe Radiofrequency-Based Devices Market (by End User), $Million, 2019-2030
Figure 10.14: Europe: Market Dynamics
Figure 10.15: Germany Radiofrequency-Based Devices Market, $Million, 2019-2030
Figure 10.16: Germany Radiofrequency-Based Devices Market (by End User), $Million, 2019-2030
Figure 10.17: France Radiofrequency-Based Devices Market, $Million, 2019-2030
Figure 10.18: France Radiofrequency-Based Devices Market (by End User), $Million, 2019-2030
Figure 10.19: Italy Radiofrequency-Based Devices Market, $Million, 2019-2030
Figure 10.20: Italy Radiofrequency-Based Devices Market (by End User), $Million, 2019-2030
Figure 10.21: U.K. Radiofrequency-Based Devices Market, $Million, 2019-2030
Figure 10.22: U.K. Radiofrequency-Based Devices Market (by End User), $Million, 2019-2030
Figure 10.23: Spain Radiofrequency-Based Devices Market, $Million, 2019-2030
Figure 10.24: Spain Radiofrequency-Based Devices Market (by End User), $Million, 2019-2030
Figure 10.25: Netherlands Radiofrequency-Based Devices Market, $Million, 2019-2030
Figure 10.26: Netherlands Radiofrequency-Based Devices Market (by End User), $Million, 2019-2030
Figure 10.27: Switzerland Radiofrequency-Based Devices Market, $Million, 2019-2030
Figure 10.28: Switzerland Radiofrequency-Based Devices Market (by End User), $Million, 2019-2030
Figure 10.29: Rest-of-Europe Radiofrequency-Based Devices Market, $Million, 2019-2030
Figure 10.30: Rest-of-Europe Radiofrequency-Based Devices Market (by End User), $Million, 2019-2030
Figure 10.31: Asia-Pacific Radiofrequency-Based Devices Market, $Million, 2019-2030
Figure 10.32: Asia-Pacific Radiofrequency-Based Devices Market, (by End User) $Million, 2019-2030
Figure 10.33: Asia-Pacific: Market Dynamics
Figure 10.34: Japan Radiofrequency-Based Devices Market, $Million, 2019-2030
Figure 10.35: Japan Radiofrequency-Based Devices Market (by End User), $Million, 2019-2030
Figure 10.36: China Radiofrequency-Based Devices Market, $Million, 2019-2030
Figure 10.37: China Radiofrequency-Based Devices Market (by End User), $Million, 2019-2030
Figure 10.38: India Radiofrequency-Based Devices Market, $Million, 2019-2030
Figure 10.39: India Radiofrequency-Based Devices Market (by End User), $Million, 2019-2030
Figure 10.40: South Korea Radiofrequency-Based Devices Market, $Million, 2019-2030
Figure 10.41: South Korea Radiofrequency-Based Devices Market (by End User), $Million, 2019-2030
Figure 10.42: Australia and New Zealand Radiofrequency-Based Devices Market, $Million, 2019-2030
Figure 10.43: Australia and New Zealand Radiofrequency-Based Devices Market (by End User), $Million, 2019-2030
Figure 10.44: Singapore Radiofrequency-Based Devices Market, $Million, 2019-2030
Figure 10.45: Singapore Radiofrequency-Based Devices Market (by End User), $Million, 2019-2030
Figure 10.46: Rest-of-Asia-Pacific Radiofrequency-Based Devices Market, $Million, 2019-2030
Figure 10.47: Rest-of-Asia-Pacific Radiofrequency-Based Devices Market (by End User), $Million, 2019-2030
Figure 10.48: Latin America Radiofrequency-Based Devices Market, $Million, 2019-2030
Figure 10.49: Latin America Radiofrequency-Based Devices Market, (by End User) $Million, 2019-2030
Figure 10.50: Latin America: Market Dynamics
Figure 10.51: Brazil Radiofrequency-Based Devices Market, $Million, 2019-2030
Figure 10.52: Brazil Radiofrequency-Based Devices Market (by End User), $Million, 2019-2030
Figure 10.53: Mexico Radiofrequency-Based Devices Market, $Million, 2019-2030
Figure 10.54: Mexico Radiofrequency-Based Devices Market (by End User), $Million, 2019-2030
Figure 10.55: Rest-of-Latin America Radiofrequency-Based Devices Market, $Million, 2019-2030
Figure 10.56: Rest-of-Latin America Radiofrequency-Based Devices Market (by End User), $Million, 2019-2030
Figure 10.57: Rest-of-the-World Radiofrequency-Based Devices Market, $Million, 2019-2030
Figure 10.58: Rest-of-the-World Radiofrequency-Based Devices Market (by End User), $Million, 2019-2030
Figure 10.59: Market Dynamics: Rest-of-the-World
Figure 11.1: Abbott Laboratories: Overall Financials, $Million, 2017-2019
Figure 11.2: Abbott Laboratories: Net Revenue (by Product Segmentation), $Million, 2017-2019
Figure 11.3: Abbott Laboratories: Net Revenue (by Region), $Million, 2017-2019
Figure 11.4: Abbott Laboratories: SWOT Analysis
Figure 11.5: AngioDynamics, Inc.: Overall Financials, $Million, 2017-2019
Figure 11.6: AngioDynamics, Inc.: Net Revenue (by Product Segmentation), $Million, 2017-2019
Figure 11.7: AngioDynamics, Inc.: Net Revenue (by Region), $Million, 2017-2019
Figure 11.8: AngioDynamics, Inc.: SWOT Analysis
Figure 11.9: ALMA Lasers (Sisram Medical Ltd): Overall Financials, $Million, 2017-2019
Figure 11.10: ALMA Lasers (Sisram Medical Ltd): Net Revenue (by Product Segmentation), $Million, 2017-2019
Figure 11.11: ALMA Lasers (Sisram Medical Ltd): Net Revenue (by Region), $Million, 2017-2019
Figure 11.12: ALMA Lasers (Sisram Medical Ltd): SWOT Analysis
Figure 11.13: AtriCure, Inc.: Overall Financials, $Million, 2017-2019
Figure 11.14: AtriCure, Inc.: Net Revenue (by Product Segmentation), $Million, 2017-2019
Figure 11.15: AtriCure, Inc.: Net Revenue (by Region), $Million, 2017-2019
Figure 11.16: ArtiCure, Inc.: SWOT Analysis
Figure 11.17: Avanos Medical, Inc.: Overall Financials, $Million, 2017-2019
Figure 11.18: Avanos Medical, Inc.: Net Revenue (by Product Segmentation), $Million, 2017-2019
Figure 11.19: Avanos Medical, Inc.: Net Revenue (by Region), $Million, 2017-2019
Figure 11.20: Avanos Medical, Inc.: SWOT Analysis
Figure 11.21: Boston Scientific Corporation: Overall Financials, $Million, 2017-2019
Figure 11.22: Boston Scientific Corporation: Net Revenue (by Product Segmentation), $Million, 2017-2019
Figure 11.23: Boston Scientific Corporation: Net Revenue (by Region), $Million, 2017-2019
Figure 11.24: Boston Scientific Corporation: SWOT Analysis
Figure 11.25: CONMED CORPORATION: Overall Financials, $Million, 2017-2019
Figure 11.26: CONMED CORPORATION: Net Revenue (by Product Segmentation), $Million, 2017-2019
Figure 11.27: CONMED CORPORATION: Net Revenue (by Region), $Million, 2017-2019
Figure 11.28: CONMED CORPORATION: SWOT Analysis
Figure 11.29: Cutera, Inc.: Overall Financials, $Million, 2017-2019
Figure 11.30: Cutera, Inc.: Net Revenue (by Region), $Million, 2017-2019
Figure 11.31: Cutera, Inc.: SWOT Analysis
Figure 11.32: Medtronic Plc: Overall Financials, $Million, 2017-2019
Figure 11.33: Medtronic Plc: Net Revenue (by Product Segmentation), $Million, 2017-2019
Figure 11.34: Medtronic Plc: Net Revenue (by Region), $Million, 2017-2019
Figure 11.35: Medtronic plc: SWOT Analysis
Figure 11.36: Merit Medical Systems, Inc.: Overall Financials, $Million, 2017-2019
Figure 11.37: Merit Medical Systems, Inc.: Net Revenue (by Product Segmentation), $Million, 2017-2019
Figure 11.38: Merit Medical Systems, Inc.: Net Revenue (by Region), $Million, 2017-2019
Figure 11.39: Merit Medical Systems, Inc.: SWOT Analysis
Figure 11.40: Smith & Nephew: Overall Financials, $Million, 2017-2019
Figure 11.41: Smith & Nephew: Net Revenue (by Product Segmentation), $Million, 2017-2019
Figure 11.42: Smith & Nephew: Net Revenue (by Region), $Million, 2017-2019
Figure 11.43: Smith & Nephew: SWOT Analysis
Figure 11.44: Stryker Corporation: Overall Financials, $Million, 2017-2019
Figure 11.45: Stryker Corporation: Net Revenue (by Product Segmentation), $Million, 2017-2019
Figure 11.46: Stryker Corporation: Net Revenue (by Region), $Million, 2017-2019
Figure 11.47: Stryker Corporation: SWOT Analysis
Figure 11.48: Venus Medical: Overall Financials, $Million, 2017-2019
Figure 11.49: Venus Medical: Net Revenue (by Region), $Million, 2017-2019
Figure 11.50: Venus Concept, Inc.: SWOT Analysis
Figure 11.51: Bramsys Indústria e Comércio Ltda: SWOT Analysis
Figure 11.52: BVM Medical Limited: SWOT Analysis
Figure 11.53: Diros Technology, Inc.: SWOT Analysis
